INTRODUCTION
Delineation of the causes and nature of disease processes is a continuing goal for all people involved in the health sciences. To the uninitiated, an almost infinite array of clinical signs, symptoms, functional and structural alterations occur with, during, or after encounters with disease-causing agents. Ascription of a specific set of changes to the effects of a single agent upon host cells or tissues is one way in which students have sought to classify and thus understand the disease-causing process. However, this approach ignores a fundamental principle of pathology, namely that range of host responses to injurious chemical or viral agents is limited to a few recognizable patterns and that these patterns of injury are mediated by a finite (and thus understandable) series of biochemical or molecular events. Therefore, the objectives of this brief review are to describe a method for interpretation of gross and microscopic lesions attributable to viral infections while emphasizing the fundamental similarity of many of these processes to other agents and to consider functional derangements mediated by viruses or chemicals using immunomodulation as an example of the principle.
GENERAL CLINICO-PATHOLOGIC FEATURES OF ACUTE AND CHRONIC VIRAL INFECTIONS
Though not invariably true, acute viral diseases tend to be accompanied by florid but short-term (2-3 weeks) virus replication cycles in tissues, whereas the chronic or persistent viral infections tend to have low (or difficult to detect) amounts of infectious virus in tissues. For acute viral infections, clinical signs are coincident with peak production of virus in tissues and thus the lesions and/or signs of disease are directly attributable to the virus. Acute infections may be limited to only one occurrence in a lifetime, may recur repeatedly throughout life once infected as with latent Herpesvirrrs siiiipkx infection, or may repeat as de i m~o infections for each distinct viral serotype as occurs with the rhinoviruses. Chronic viral diseases are operationally distinguished from the acute forms by the fact that manifestations of disease persist for long periods of time after the initiating infectious event. In chronic viral infections it is important to distinguish the effects of a permanently damaged organ vs damage associated with the continued presence of viral materials in tissues. Thus, static (i.e., the cerebellar hypoplasia) or the progressive (Le., the hydrocephalus) sequelae to acute, self-limiting disease are chronic in their clinical expression and may occur without residual evidence of pre-existent viral infection. There are many examples of chronic (persistent) viral infections. Generally, both the virus and progressive lesions attributable to virus infection coexist in tissues. In these conditions, the course of disease is slow, progressive, and, for the individual, is frequently fatal. Examples of host/virus interactions in which progressive disease associated with progressive infection occur, are old dog encephalitis, a canine distemper virus-associated neurologic disease, scrapie and related spongiform encephalopathies including transmissible mink encephalopathy, and the non-oncogenic lentivirus infections of animals, namely visna, maedi, and equine infectious anemia.
The final form of chronic hostlviral interaction that may or may not have expressed virus associated with it, is that of virus-induced neoplastic transfor-mation. It is now well recognized that a number of different viral agents of the papilloma-papova, oncomavirus and also the herpesvirus groups are capable of inducing malignant transformation in susceptible host cells. This transformational event can occur in the presence of the etiologic agent as occurs with most cases of feline leukemia virus infection, or it can occur in the absence of complete viral infectious particles, as occurs with Marek's disease, a herpesvirus infection of chickens, certain of the herpesvirus-induced lymphomas in monkeys, and in Epstein-Barr virus-associated Burkitt's lymphoma of man.
LOCAL COhlPONENTS OF VIRUS-ASSOCIATED LESIONS: VIRAL CYTOPATHIC EFFECTS

Viral Cytopatliic Eflects
Structural or functional lesions attributed to a typical viral infection (1, 2, 6) may be broadly divided into local and systemic manifestations (Table I) . Local responses to foci of viral infection may include 1 or all 5 of the components listed in Table I . Of these, the most diagnostically helpful is the cytopathic effects (CPE) of the virus upon the tissues. Generally speaking, visible accumulations of viral material in cells (e.g., inclusion bodies) assist in the identification of the virus involved. These structures are recognized by light microscopy as homogeneous eosinophilic, or sometimes slightly basophilic intracytoplasmic or intranuclear aggregates of viral proteins, nucleoprotein complexes or complete virions. Unfortunately, these diagnostic structures may be difficult to find in vivo.
The fundamental physiological change induced by viruses on host cells is progressive cellular swelling. This increase in the size and change in shape of an infected cell occurs with time and is thought to be due to virus-mediated inhibition or interference with the membrane-bound sodium pump mechanisms (e.g., water transport) in infected cells. Influx of water disrupts cellular organelles, dilates rough and smooth endoplasmic reticulum and produces mitochondria1 swelling. Histologically, this phenomenon is recognized as cloudy swelling and hydropic degeneration. Of course, cells and tissues do not swell indefinitely. With time, infected cells either rupture and discharge their contents including both complete and incomplete virus for subsequent infection of adjacent cells or infected cells may fuse with several uninfected adjacent cells to produce multinucleated syncytial giant cells (10) . Cytolysis is recognized in vivo as necrosis. The contents of lytically infected cells may coalesce to form vesicles, may be expressed as expanding foci of coagulation necrosis, or may only be detected as death of single cells. 111 vivo, syncytium formation between adjacent host cells is mediated by virus-specific cell membrane-bound glycoproteins. In addition to producing expanding foci of infection, cell fusion facilitates cell-to-cell transmission of viral genetic information, thereby serving as one method by which viruses are retained within tissues of an actively immune individual.
The second major type of viral/host cell interaction is that of the steady state or persistent infection (5) . In this instance, a state of persistence is established in which cellular lysis is either not obvious or is not a major component of the hostlvirus relationship. Rather, the host cell will shed viral material, whole infectious virus, or viral polypeptides either intermittently or constantly throughout the life of the cell. There is little doubt that persistently infected cells experience progressive degenerative changes when compared to their uninfected counterparts, but this type of change is subtle and difficult to delineate. Even though cellular proliferation may occur in the recovery phases of many viral infections it is characteristic of persistent viral infections such as those induced by the pox and papillomaviruses. The proliferative (hyperplastic) response may be induced directly by virus or virusassociated products or may occur secondary to the physiological repair response characteristic of that tissue. Thus, the steady state or persistent virus infections have a number of important long-term ramifications, not only for the virus but also for the host tissues.
The third virudhost interaction is that of malignant transformation. It is clearly beyond the scope of this review to provide a detailed discussion of the mechanisms of transformation associated with the oncogenic viruses. One of the tenets of modem biology that has emerged from the virtual explosion in molecular genetics is the discovery that normal host cells contain genes whose expression is associated with malignant transformation. These cellular oncogenes hybridize with and are thus identical to gene sequences found in retroviral RNA. Normally, these genes, found in all cells, are strongly repressed. It is thought that oncogenes are activated: during the process of transcription and translation of proviral DNA, secondary to and associated with insertion of viral DNA into cellular DNA or can be expressed by chemical action on host DNA. The
Antiviral Itiitiitirte Respomes
Both specific and nonspecific inflammatory responses to viral infection almost invariably accompany the above described types of cellular damage and thus complicate the appearance of the gross and histopathologic lesions (2, 3). The only exception to this rule is that lesions induced by prions (scrapie, transmissible mink encephalopathy, etc.) do not have an obvious inflammatory component. Excluding prior-associated disease, foci of viral infection first experience damage mediated by the nonspecific inflammatory response. Later, developing immune responses may predominate.
The nonspecific inflammatory response is mediated by released host cell constituents and not by immunological phenomena. Lysozymes, proteases and other substances affect local blood vessels producing vasoconstriction and/or increased capillary permeability, thereby providing a mechanism for leukocyte emigration into the tissues. Activation of the soluble mediators contributes to fluid and cellular extravasation. The neutrophilic response is transient and in most viral diseases constitutes only a minor component of the inflammatory exudate. This transient response is rapidly superseded by virus-specific immune inflammatory cell infiltration (Table 11 ). Not only is inflammation mediated by humoral and cellular factors generated as the disease progresses, but numerous amplification pathways are activated which serve to enhance the inflammatory response. The net effect of this developing and progressive process is the accumulation of leukocytes within these areas of viral production. However, unlike the transient inflammatory response induced by cellular necrosis, most of the leukocytes noted in this later phase of infection are of mononuclear cell origin, a designation which includes both B and T lymphocytes, monocytes, macrophages and natural killer (NK) cells (7, 9, 11) .
.The chief function of infiltrating B cells is to produce immunoglobulin and/or differentiate into plasma cells. Antibody may be readily identified within these tissues using appropriate labeling techniques. Antibody serves to neutralize extracellular infectious virus as well as directing effector cells to virus-in-TOXICOLOGIC PATHOLOGY fected cells through the mechanisms of antibody-directed cellular cytotoxicity (ADCC) or complementdependent cytolysis. A final mechanism whereby antibody is capable of affecting the local inflammatory response is by modulating or removing viral proteins from the surfaces ofinfected cells without killing them.
A cytotoxic T-cell effector response is an integral part of the inflammatory process, particularly in the acute viral diseases. In general, cytotoxic T-cell responses tend to be short-lived and are very susceptible to down regulation by suppressor cells. T cells mediate their effect by direct or intimate contact with virus-infected cells and subsequent release of cytotoxic factors which have the effect of lysing and destroying not only the infected cells, but also adjacent uninfected cells. This, of course, produces more cellular debris for incitement of other components of the inflammatory response and thus facilitates nonspecific recruitment of inflammatory cells into lesions as the infection progresses. Monocyte-macrophages are increasingly recognized as effector cells responsive to viral infection. In general, monocytes in virus-associated inflammatory responses undergo iri sitii maturation and activation.
The latter may, in part, be mediated by T-cell lymphokines. Frequently, macrophages are directly susceptible to infection by the offending virus and may well serve as an additional cellular site of virus production and subsequent dissemination.
The final infiltrating cell type incriminated in hostorigin antiviral defenses is the natural killer (NK) or large granular leukocyte (LGL) cytotoxic cell. These cells are thought to be of T-or prethymic T-cell origin, respond to T-cell growth factor and express cell membrane receptors for IgG-Fc. They have the functional property of pre-immune recognition and subsequent cytolytic destruction of many different foreign cells in vitro, including cancer cells and virus-infected cells expressing membranebound viral antigens. Although direct iit vho evidence for the involvement of NK in local viral lesions is fragmentary, correlative data for the nude mouse implicates this cell type as responsible for the apparent intrinsic resistance of this T-cell-deficient animal to many murine viral pathogens.
Vasctilitis
It is important to recognize that many viral infections, at least in the acute phases, are accompanied by a vasculitis. Vasculitis is a frequently overlooked component of a tissue ,response to viral infection and may be localized or generalized in nature. There is no doubt that some intrinsic level of vasculitis is necessary in order to provide a mechanism for egress of blood-borne inflammatory factors into regions of virus-induced cellular damage.
Frequently, vasculitis may be severe enough to induce additional nonspecific tissue damage via hemorrhage and/or ischemia. In many instances the vasculitis can be attributed to direct viral infection of the endothelial cells. However, it is known that vasculitis can occur indirectly by induction of disseminated intravascular coagulation (D1C)-like phenomena, as occurs with Newcastle disease virus in chickens, Dengue fever virus infection in man, and infectious canine hepatitis (canine adenovirus I) infection in dogs. Also, vasculitis can occur indirectly in which viral antigen-antibody complexes, coated with complement components, may be deposited in organs or tissues distantly removed from the sites of viral production. These complexes are phlogistic and attract inflammatory cells to these sites of deposition.
Celltilar Proliferation and Fibrosis
The final local component of a virus-induced lesion, particularly ifthe process is in the healing phase, is repair by substitution (e.g., fibrosis), or by proliferation and subsequent replacement with uninfected parenchymal cells. Like many other phenomena, the extent and functional significance of fibrosis will vary with the extent and severity of tissue damage and the repair capabilities of that tissue. Organs with limited or nonexistent postnatal replicative potential such as the brain are at greatest risk for development of permanent deficits.
SYSTEMIC COMPONENTS OF VIRUS-ASSOCIATED LESIONS
In addition to local effects, many viruses are pantropic and thus result in systemic infections. Within broad limits, the same sequence of events as occurs locally will occur in all tissues. However, the systemic phase of a viral infection can have independent long-term and even metabolic consequences to the host. Neurological deficits are common. A common effect of systemic viral disease is transient or permanent damage to lymphoreticular tissues. Thus, lesions of thymic or bursa1 atrophy and resultant depletion of lymphoid tissues produce an immunocompromised host which is at great risk for development of secondary, opportunistic infections.
There are a number of viral diseases of animals in which an immune complex component has been demonstrated. Candidate viruses include feline infectious peritonitis virus, feline leukemia virus, equine infectious anemia virus, bovine virus diarrhea, Aleutian disease virus infection in mink, infectious canine hepatitis and canine distemper virus infection in dogs, and the viruses of African swine fever and hog cholera. Still other viruses may produce secondary metabolic disease by virtue of their destructive effects upon critical host tissues. Thus, diabetes mellitus seen in both mice following infection with certain strains of encephalomyocarditis virus infection and cattle with foot and mouth disease infection, is attributable to pancreatic islet cell destruction. Recently, distemper virus infection in mice was shown to produce an obesity syndrome in rodents surviving the acute infection. Finally, lymphocytic choriomeningitis virus infection in mice has been shown to interfere with growth hormone production and/or release, thereby producing dwarfed hyperglycemic individuals. Thus, given all of these possible effects and outcomes, it is not surprising that the pathologic effects of viruses in host tissues are the net result of a complex biological process.
A STRATEGY FOR ASSESShfENT OF VIRAL AND
CHEhllCAL IhlhlUNOTOXICANTS
The second objective of this selective review of viral pathology was to address the issue of longterm functional alterations induced by viral diseases. It is in this area that toxicologic pathology and microbiological pathology converge to share a common pathway of significance (12) . Long-term functional disturbances are more common than is ordinarily appreciated and, in general, tend to involve the control networks of the body, namely the central nervous, endocrine and hemolymphatic systems. Disturbances in form (e.g., gross and microscopic lesions) in these 3 organ systems follow functional changes.
It is beyond the scope of this review (and of this author's knowledge) to provide an in-depth appreciation of these 3 systems. Rather, I would like to address one area, namely the mechanisms and methods of studying the effects of viruses and chemicals (immunotoxicology) upon the immune system. The similarities are striking. For viruses, significant effects upon lymphoid function seem to have at least 2 requirements: a systemic infection phase and a hemolymphatic tropism. Chemicals, being nonreplicating, must exert a long-term effect, by altering either a stem cell function directly or by permanent disruption of 'the normal immune response microenvironment. This effect is dose, route, age and gender dependent. At the outset, it is important to determine if functional disruptions of immunity are primary to viral infection or chemicaI intoxication or are secondary to dysfunctions in other tissues. In the case of chemicals or drugs, damage to an unrelated organ such as the liver may produce biologically significant changes in immune status. If the goal of the screening process is to identify primary immunotoxicants, then the dose/exposure regimen must either be adjusted so that nonlymphoid tissues are morphologically and biochemically normal or consideration must be given to the use of analogue chemicals which spare nonlymphoid organs. It is important to stress that the immediate consequences of infection or poisoning may differ significantly from long-term consequences. If an immunological defect is suspected, accurate description of the defect requires a systematic approach to the analysis of individual components of immunity.
Delineation of immune disruption begins with a careful study of available historical records and experiences with the species under study. General evaluation should include physical appearance, determination of lifespan and reproductive capacity, alterations in susceptibility to disease causing potential of both commensal and pathogenic infectious agents within the colony and careful determinations of changes in backgrounds or spontaneous tumor incidence. Gross and histopathologic examinations of tissues are an essential component of the process. In addition to generation of routine hematology profiles, primary (e.g., thymus and bone marrow) and secondary (e.g., lymph nodes and spleen) lymphoid tissues should be examined. In the latter, attention should be directed to microscopic evaluation of T-cell dependent and B-cell dependent regions for the following general categories of relative change: increase in cellularity (hyperplasia), decrease in cellularity (depletion) or no changes from the normal range.
Tmmunotoxicants, if biologically significant, must induce hyper-or hypo-functional changes in immune cells/populations. Development and selective implementation of a basic screening program as recommended by Norbury (8) should permit the investigator to determine functional status without adding significantly t o the cost of toxicologic evaluation (Table 111 ). Norbury recommends the following screening panel: determination of serum concentrations of IgG, IgM and IgA by radial immunodiffusion or nephelometry; lymphocyte blastogenesis with T-and B-cell mitogens; total and differential leukocyte counts; and carbon clearance assay for evaluation of the reticuloendothelial system. The screen assays recommended are essentially passive in that they can be implemented into the toxicological screening process without immunologic intervention in animals on study.
Active evaluation of the effects of toxicants/viruses upon the immune system requires a different experimental design in which toxicant-exposed, or virus-infected animals are immunized or manipulated for the express purpose of identifying and quantitating the suspected immune defect (Table  IV) . For this the immune response to various antigens may compartmentalize the defect. For mice, the immune response to dextran sulfate and/or bacterial lipopolysaccharide (LPS) is strain-dependent and generally considered to be a specific test of B-lymphocyte function independent of T-helper or T-suppressor modulation. Similarly, plaque-forming response to ovine erythrocytes (e.g., Jerne plaque technique) is well established as a test for T-cell dependent B-lymphocyte functions. Cutaneous reactivity or in vitro blastogenic response to purified protein derivative following sensitization with Mycobacteria sp. is generally recognized as a T-cell effector-specific manifestation of cellular immunity. Similarly, cutaneous allograft rejection studies, while tedious, measure the same phenomenon.
Recently, pharmacologic and virologic effects upon lymphokine production by immune cells in vitro have shown great promise in delineation of immune defects. Perturbations in production or responses to these lymphokines can occur in the absence ofstructural abnormalities. Interleukin-2 (IL-2) or T-cell growth factor is best measured by employing IL-2-dependent-murine T-lymphocyte cell lines. Interleukin-1 production by LPS-stimulated macrophages is detected using an enhanced thymocyte blastogenesis assay. Many materials of toxicologic and pharmacologic importance alter interleukin biology directly or indirectly by modulating arachidonic acid metabolism and these can be detected by measuring prostaglandin (PG) metabolites in media and cellular extracts or by employing PG-inhibitors such as indomethacin.
Finally, certain immune functions appear to be mediated by cells of presumed thymic origin known as natural killer or NK cells. NK cells, enhanced by local interferon production, are thought to be the cytotoxic effector cells responsible for nonimmune resistance to tumor cells, virus-infected cells and certain bacterial and parasitic diseases. The beige mouse mutant is known to be functionally NK-deficient. Cytotoxic capabilities of these cells are easily determined by 5 1 C h r~m i~m release assays using well characterized NK-susceptible target cells.
Through a combination of these two broad approaches, a number of different mechanisms or combinations thereof have been delineated for both viral and chemical-induced immunomodulation (1 1). Again, the similarities between the effects of chemicals and viruses are emphasized. These are outlined in Table V . Most viruses and chemicals have a depressive effect upon normal immune function though this is not invariably true. By far the most common and easily appreciated suppressive effect is direct cytotoxic damage to the cells and supporting network of the immune system. For chemicals, the timing, dose and route of exposure are important variables. In addition to cytolysis or cytostasis, both viruses and chemicals have been shown to alter functional aspects of immunity. However, for most, the mechanism of action is obscure. Finally, of course, neoplastic transformation initiated or promoted by either viruses or chemicals accounts for many instances of immunosuppression. As mentioned previously, both classes of carcinogenic agents appear to act at the cellular level by derepression of cellular oncogenes.
CONCLUSIONS
The objectives of this selected topic review were 2-fold: (1) to describe the components of virus-induced lesions at both the cellular and organhsue level and to point out the contributions of both the inflammatory and immune response to the histogenesis of these lesions; and (2) to emphasize the subtle and long-term effects of viral infections upon various physiological functions and the similarities of action between viruses and chemicals using immunomodulation as the model system.
The importance of these 2 points in modem toxicologic pathology is obvious. Structural alterations attributable to drugs, chemicals and intoxicants may well be viral in origin. The long-term effects of viral infection can easily be confused with the immunotoxicant effects of many substances currently being tested. Lessons and techniques developed for evaluation of virus-mediated immune dysfunctions are easily transferable to the study of drugs and intoxicants. As a consequence, the subdisciplines of immunopharmacology and immunotoxicology have emerged. It is hoped that the heightened awareness of similarities of action for these two broad classes of agents will provide the toxicologic research scientists with the investigative tools needed to address this problem within the context of both the shortterm objectives and the long-term goals of their own research projects.
